hyoscine_hydrobromide - Drug Details
๐Ÿ“Š Estimates hyoscine_hydrobromide Dialyzability By Different_Modalities

hyoscine_hydrobromide

Complete Drug Information

Drug Name
hyoscine_hydrobromide
Trade Names
Transderm Scop
Pregnancy Category
AU: B2
Bioavailability
20-40%
Routes of Administration
Oral, transdermal, ophthalmic, subcutaneous, intravenous, sublingual, rectal, buccal, transmucosal, intramuscular
Metabolism
Liver (CYP3A4)
Elimination
5 hours
Excretion
Kidney
Formula
C17H21NO4
Molar Mass
303.358
Drug Class
Antimuscarinic Deliriant Antiemetic Amnestic
Volume of Distribution
C17H21NO4

๐Ÿคฐ Pregnancy Category Information

Category: AU: B2

Drugs which have been taken by only a limited number of pregnant women and women of childbearing age, without an increase in the frequency of malformation or other direct or indirect harmful effects on the human fetus. Animal studies are inadequate or may be lacking, but available data show no evidence of an increased occurrence of fetal damage.